News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) and Bristol-Myers Squibb Company (BMY) to Present New Data at American Diabetes Association 73rd Scientific Sessions®



6/14/2013 7:07:53 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AstraZeneca (NYSE: AZN) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that 33 abstracts on the companies’ research in diabetes have been accepted for presentation at the 73rd Scientific Sessions® of the American Diabetes Association (ADA) in Chicago, June 21-25.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES